Document is current
Any future updates will be listed below
-
Authors
Eburne, Philip
Chapple, Iain
Sharma, Praveen
-
Funding
Funding for this research was provided by:
Birmingham Biomedical Research Centre
- License Information
-
More Information
Article History
Accepted: 8 October 2025
First Online: 1 November 2025
Declarations
:
: No animal or human subjects by the authors were used in this study.
: Mr PE has not COIs to declare.Dr PS serves as Director of Palms Health Ltd and provides consultancy services to the oral health industry: Prevora and Kenvue and receives trial funding from the oral health industry: Haleon and Unilever.Dr ILC serves as Director of OHI Consulting Ltd, provides consultancy services to the oral health industry: Haleon, Unilever, Philips, Kenvue. He is an honorary consultant to NHS England’s Office of the Chief Dental Officer. He has been a co-chair for the European Federation of Periodontology (EFP) Workshops and serves as a board member of the Platform for Better Oral Health in Europe (representing the EFP).
: The authors declare no competing interests.
